Lv11
10 积分 2024-06-30 加入
Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer with [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI: Lesion-to-Lesion Comparison with Pathology
31分钟前
待确认
Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer
5小时前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
1个月前
已完结
Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis
3个月前
已完结
Neoadjuvant Stereotactic Ablative and Hypofractionated Radiotherapy for Oligometastatic NSCLC
4个月前
已完结
Is surgery worthwhile in locally-advanced NSCLC patients with persistent N2-disease after neoadjuvant therapy?
4个月前
已完结
Determinants of successful minimally invasive surgery (MIS) for resectable non-small cell lung cancer (NSCLC) after neoadjuvant therapy
4个月前
已完结
RESCUE BT 2, a multicenter, randomized, double-blind, double-dummy trial of intravenous tirofiban in acute ischemic stroke: Study rationale and design
4个月前
已完结
Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non–small cell lung cancer
4个月前
已完结
Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience
4个月前
已完结
皖公网安备34019202002308
